| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.33B | +20.2% |
| Cost of Revenue | $257.5M | +69.9% |
| Gross Profit | $2.07B | +16.0% |
| R&D Expense | $408.0M | +26.4% |
| SG&A Expense | $477.1M | -1.0% |
| Operating Income | $1.18B | +20.9% |
| Interest Expense | $59.3M | +83.0% |
| Pre-tax Income | $1.27B | +34.1% |
| Income Tax | $289.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.21B | +25.6% |
| Short-term Investments | $1.79B | -4.9% |
| Accounts Receivable | $278.9M | +26.5% |
| Inventory | $111.8M | +9.6% |
| Current Assets | $3.55B | +5.0% |
| Total Assets | $7.17B | +18.6% |
| Current Liabilities | $804.4M | +134.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $978.0M | +21.9% |
| Capital Expenditures | $230.4M | +66.0% |
| Investing Cash Flow | -$719.6M | +11.3% |
| Financing Cash Flow | -$11.9M | -115.8% |
| Free Cash Flow | $747.6M | +12.6% |
| +29.6% |
| Net Income | $984.8M | +35.4% |
| EPS (Basic) | $21.04 | +31.7% |
| EPS (Diluted) | $19.81 | +32.1% |
| Total Liabilities |
| $1.18B |
| -5.3% |
| Stockholders' Equity | $5.98B | +24.8% |